ReviewFrontiers in immunology2022

ALT-803 in the treatment of non-muscle-invasive bladder cancer: Preclinical and clinical evidence and translational potential.

Wujun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.